Related Experiment Video
Updated: Oct 10, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Regulatory Overview and Considerations for Medical Countermeasures Developed for Radiological/Nuclear Incident
Mary Homer1, David Cassatt2, Paul W Price2
1Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA.
Abstract:
After the terrorist attacks on September 11 and the anthrax attacks in 2001, the United States Government (USG) implemented several pieces of legislation to enable the federal government to prepare for future threats, including managing and funding product development of medical countermeasures (MCMs). The Project BioShield Act of 20041 and the Pandemic and All Hazards Preparedness Act (PAHPA) of 20062 (with reauthorizations in 20133 and 20194) described and fine-tuned the scope and mission of different agencies in this effort. The Department of Homeland Security is charged with issuing material threat determinations5 from which organizations can model threat scenarios to determine potential health outcomes. The numbers from these models serve as thresholds for planning purposes. Within the radiological and nuclear (Rad/Nuc) space, there are two primary threats that have been identified as threats to national security: nuclear detonation (NucDet) and radiological dispersal devices (RDDs). NucDet is deemed the higher priority threat for planning and MCM development because of its greater potential impact. Health effects associated with nuclear power plant accidents are also considered in planning and preparedness.
Related Concept Videos
Biological Effects of Radiation
Drug Regulation
Radiological Investigation I: X-ray and CT
Nuclear Power
Nuclear Fuels
Nuclear fuel consists of a fissile isotope, such as uranium-235, which must be present in sufficient quantity to provide a...
Pharmaceutical Poisoning: Potential Scenarios
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...